Is Madrigal Pharmaceuticals Inc halal to invest in?

As of July 2026, Madrigal Pharmaceuticals Inc MDGL is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Madrigal Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Madrigal Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Madrigal Pharmaceuticals Inc?

Muslim investors may consider investing in Madrigal Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Madrigal Pharmaceuticals Inc classified as HALAL?

Musaffa determines the Shariah status of Madrigal Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Madrigal Pharmaceuticals Inc updated?

The Shariah compliance status of Madrigal Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Madrigal Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Madrigal Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Madrigal Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MDGL Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Madrigal Pharmaceuticals Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Madrigal Pharmaceuticals Inc. Stock Analysis MDGL

United States Health Care Large Cap Report: Q1, 2026

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company is headquartered in West Conshohocken, Pennsylvania and currently employs 915 full-time employees. The company went IPO on 2007-02-06. The firm is focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. The Company’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-b agonist designed to target key underlying causes of MASH. Rezdiffra is the medication approved by the United States Food and Drug Administration (FDA) for the treatment of MASH with moderate to advanced fibrosis (consistent with stages F2 to F3). Rezdiffra is a prescribed medicine used along with diet and exercise to treat adults with nonalcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver. An ongoing Phase III outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (consistent with stage F4c).

Key Statistics of Madrigal Pharmaceuticals Inc (MDGL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$542.64$552.73

Today's Open

$546.78

Volume

223.81K

P/E Ratio (TTM)

52 Week Range

$286.44$615.00

Market Cap

13.04B

Avg. Volume

422.46K

Dividend Yield

Financial Metrics & Statements of Madrigal Pharmaceuticals Inc (MDGL)

Super Investors Invested in Madrigal Pharmaceuticals Inc (MDGL)

FAQ's for Madrigal Pharmaceuticals Inc (MDGL)

As of July 2026, Madrigal Pharmaceuticals Inc MDGL is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Madrigal Pharmaceuticals Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Madrigal Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Madrigal Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Madrigal Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Madrigal Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.